Celecoxib/Diacerein

塞来昔布/双醋瑞因

Report date: 2024/03/18 12:20:37

Base Information

Drug NameCelecoxib/Diacerein
Drug Alias NameDiacerein/celecoxib双醋瑞因/塞来昔布Diacerein+celecoxib双醋瑞因+塞来昔布Celecoxib+Diacerein +[6] 
ClassificationSmall molecules
Mechanisms of ActionInterleukin-1 beta inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Interleukin-1 beta
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes DiacereinCelecoxib
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZydus Lifesciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZydus Lifesciences Ltd
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A